PHARMACY

Study shows fibromyalgia related to brain blood flow abnormality

BY Michael Johnsen

NEW YORK According to a WebMD report published Monday, a new brain scan study concludes that fibromyalgia is related to abnormalities of blood flow in the brain.

“Fibromyalgia may be related to a global dysfunction of cerebral pain-processing,” stated study author Eric Guedj, a doctor with Centre Hospitalo-Universitaire de la Timone, in Marseille, France. “This study demonstrates that these patients exhibit modifications of brain perfusion not found in healthy subjects and reinforces the idea that fibromyalgia is a ‘real disease.'”

Fibromyalgia is a chronic disorder characterized by widespread muscle pain and fatigue. It affects mostly women. For this study, researchers took brain scans on 20 women with fibromyalgia and 10 women without the condition.

Researchers confirmed that patients with fibromyalgia exhibited brain perfusion abnormalities in comparison to the healthy participants. These abnormalities corresponded with the severity of the disease. An increase in blood flow was found in areas of the brain involved in sensing pain and a decrease was found within an area thought to be involved in emotional responses to pain.

“We found that these functional abnormalities were independent of anxiety and depression status,” Guedj said in the news release.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?
PHARMACY

FDA announces recall of Tyco ReliOn single-use syringes

BY Alaric DeArment

ROCKVILLE, Md. Food and Drug Administration said Wednesday that Tyco Healthcare Group is recalling a lot of its ReliOn single-use syringes for diabetics.

The recall affects lot number 813900, which contines 100 31-gauge ReliOn hypodermic syringes containing 1 milliliter of U-100 insulin. Tyco distributed 4,710 boxes in the recalled lot, totaling 471,000 individual syringes. Wal-Mart sold the syringes at its stores between Aug. 1 and Oct. 8, and Tyco voluntarily recalled the lot Oct. 9. Wal-Mart has sent letters to 16,500 customers notifying them of the recall and posted an announcement on its Web site.

Can-Am Care distributes the syringes and sells them through Wal-Mart and Sam?s Club stores under the Reli-On brand. The mass-merchandiser has requested that all users of this type of syringe return those that come from the recalled lot.

The FDA said that during the packaging of the syringes, some syringes labeled for use with U-40 insulin were mixed with syringes labeled for use with U-100 insulin and then packaged individually and in boxes as 100 units for use with U-100 insulin. Tyco has received one report of complications due to use of a syringe from the recalled lot.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?
PHARMACY

Medical information leaks prompt added awareness about records security

BY Alaric DeArment

CHICAGO News reports about high-profile victims of personal medical information security and privacy breaches highlight the need to educate and inform healthcare professionals, their employees, the media and consumers on privacy protection, an professional organization for the health information management industry said Thursday.

The American Health Information Management Association said that educating healthcare professionals on privacy and security issues is an ongoing concern within the health information industry.

“It’s critical for healthcare professionals to receive more education about good privacy practices and appropriate interpretation of HIPAA and other regulations,” AHIMA president Wendy Mangin said.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?